At the time of my last update in February on the state of patent eligibility law, the Supreme Court had recently declined to grant cert on Athena, Vanda, Berkheimer, Cellspin, Power Analytics, ChargePoint and Trading Technologies. The Court has now additionally denied
Continue Reading Patent Eligibility: Legislative Change Still Appears Far Away
When investors survey the digital health sector today, they see nearly every number trending upward.
There is more deal volume than VCs have seen in past years, with the third quarter of 2020 outpacing anything they’ve seen in the past
Continue Reading Rock Health Summit 2020 Takeaways: Digital Health Is Firing on All Cylinders
Virtual healthcare staked out exciting new ground with the recently announced $18.5 billion merger of telemedicine pioneer Teladoc Health and chronic disease management company Livongo.
The deal illustrates the growing appetite among public-market investors for innovative healthcare solutions. Analysts at
Continue Reading More Consolidation, IPOs Ahead for Digital Health Companies
Venture investors are pleased to see digital health companies continue to transform the healthcare system despite unprecedented challenges brought by the COVID-19 pandemic.
Funding for digital health startups broke records in the first half of 2020 as adoption of telemedicine
Continue Reading Digital Health Investors Offer Cautious Optimism at Rock Health H1 2020 Event
Last week, the U.S. Court of Appeals for the Federal Circuit issued its second and third decisions in American Axle & Manufacturing v. Neapco Holdings and Neapco Drivelines, the case we’ve previously discussed in which the following claim (claim 22)
Continue Reading Federal Circuit Still Spinning Its Wheels on American Axle
The spread of COVID-19 has created a defining moment for the digital health sector, as many products and services once considered “nice-to-haves” have transformed into necessities. Venture investors and company founders may be operating remotely but they are still hard
Continue Reading COVID-19 Pandemic Shines a Spotlight on Digital Health in Q2 2020
In my post back in March 2018, I analyzed an upward change in allowance rates in the 36XX art units based on my practitioner’s observation that inventions were finally beginning to be more frequently found eligible for patenting following a
Continue Reading Further Thawing: Patent Eligibility Rates Continue Trending Upward in the Wake of USPTO Guidance
Despite the changes and uncertainty rippling across the entire venture-backed startup ecosystem, the digital health sector saw its best first quarter since analysts began tracking its performance more than a decade ago, logging $3.1 billion across 107 deals, according
Continue Reading Digital Health Investments See Significant Uptick in Q1; Investors Consider COVID-19 Impacts in Coming Months
On April 30, the Federal Circuit issued a precedential opinion in Uniloc v. LG Electronics, concerning claims to a software invention for a local communication system that reduced latency for parked secondary systems, e.g., when connecting a local wireless peripheral
Continue Reading Patent Prosecution Practice Tip: No Need to Articulate Advantages Within Claim
On Thursday, April 23, the USPTO released a new study entitled “Adjusting to Alice: USPTO patent examination outcomes after Alice Corp v. CLS Bank International.” The report illustrates the dramatic impact of two developments in the application of § 101
Continue Reading New USPTO Study Examines the Effects of Alice and USPTO Guidelines on Patent Eligibility
